PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
0.9500
+0.0200 (2.15%)
At close: Jun 5, 2025, 4:00 PM
0.9500
0.00 (0.00%)
After-hours: Jun 5, 2025, 7:26 PM EDT
PMV Pharmaceuticals Market Cap
PMV Pharmaceuticals has a market cap or net worth of $49.36 million as of June 5, 2025. Its market cap has decreased by -56.59% in one year.
Market Cap
49.36M
Enterprise Value
-116.14M
1-Year Change
-56.59%
Ranking
Category
Stock Price
$0.95
Market Cap Chart
Since the IPO on September 25, 2020, PMV Pharmaceuticals's market cap has decreased from $1.61B to $49.36M, a decrease of -96.94%. That is a compound annual growth rate of -52.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2025 | 49.36M | -36.84% |
| Dec 31, 2024 | 78.14M | -50.73% |
| Dec 29, 2023 | 158.59M | -60.08% |
| Dec 30, 2022 | 397.29M | -62.10% |
| Dec 31, 2021 | 1.05B | -61.94% |
| Dec 31, 2020 | 2.75B | 70.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 687.38B |
| Johnson & Johnson | 369.72B |
| AbbVie | 331.15B |
| Novo Nordisk | 324.15B |
| UnitedHealth Group | 268.37B |
| Abbott Laboratories | 233.03B |
| Novartis AG | 230.96B |
| AstraZeneca | 225.55B |